Literature DB >> 25947654

Fusion in cancer: an explanatory model for aneuploidy, metastasis formation, and drug resistance.

Marieke Mohr1, Kurt S Zaenker, Thomas Dittmar.   

Abstract

Aneuploidy, metastasis formation, and drug resistance are major issues to overcome in most cancers. If there exists common underlying proceedings for the formation of these phenomena is still unknown. The searching and thereby better understanding of causal mechanisms could promote the generation of drugs targeting the ultimate cause of these cancer promoting events. The merging of a cancer cell with another cancer cell or normal cell could be one explanation how cancer cells could gain advantageous properties and escape eliminating cell fates thereby foster cancer progression. This chapter summarizes how cell-cell fusion could directly be involved in the pathogenesis of cancer and which often cancer associated mechanisms, like viral infections or chronic inflammation, are hitherto proposed to trigger cell fusion in cancer context.

Entities:  

Mesh:

Year:  2015        PMID: 25947654     DOI: 10.1007/978-1-4939-2703-6_2

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  15 in total

1.  A second transmissible cancer in Tasmanian devils.

Authors:  Ruth J Pye; David Pemberton; Cesar Tovar; Jose M C Tubio; Karen A Dun; Samantha Fox; Jocelyn Darby; Dane Hayes; Graeme W Knowles; Alexandre Kreiss; Hannah V T Siddle; Kate Swift; A Bruce Lyons; Elizabeth P Murchison; Gregory M Woods
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-28       Impact factor: 11.205

2.  Genome remodeling upon mesenchymal tumor cell fusion contributes to tumor progression and metastatic spread.

Authors:  Lydia Lartigue; Candice Merle; Pauline Lagarde; Lucile Delespaul; Tom Lesluyes; Sophie Le Guellec; Gaelle Pérot; Laura Leroy; Jean-Michel Coindre; Frédéric Chibon
Journal:  Oncogene       Date:  2020-04-02       Impact factor: 9.867

Review 3.  Cell fusion in cancer hallmarks: Current research status and future indications.

Authors:  Hao-Fei Wang; Wei Xiang; Bing-Zhou Xue; Yi-Hao Wang; Dong-Ye Yi; Xiao-Bing Jiang; Hong-Yang Zhao; Peng Fu
Journal:  Oncol Lett       Date:  2021-05-16       Impact factor: 2.967

4.  Optimization study of plasmonic cell fusion.

Authors:  Julia Belansky; Dvir Yelin
Journal:  Sci Rep       Date:  2022-05-03       Impact factor: 4.996

Review 5.  Tissue Regeneration in the Chronically Inflamed Tumor Environment: Implications for Cell Fusion Driven Tumor Progression and Therapy Resistant Tumor Hybrid Cells.

Authors:  Thomas Dittmar; Kurt S Zänker
Journal:  Int J Mol Sci       Date:  2015-12-19       Impact factor: 5.923

6.  Lipopolysaccharide (LPS) Promotes Apoptosis in Human Breast Epithelial × Breast Cancer Hybrids, but Not in Parental Cells.

Authors:  Sabrina Fried; Songuel Tosun; Gabriele Troost; Silvia Keil; Kurt S Zaenker; Thomas Dittmar
Journal:  PLoS One       Date:  2016-02-10       Impact factor: 3.240

7.  Up-regulation of syncytin-1 contributes to TNF-α-enhanced fusion between OSCC and HUVECs partly via Wnt/β-catenin-dependent pathway.

Authors:  Ting-Lin Yan; Meng Wang; Zhi Xu; Chun-Ming Huang; Xiao-Cheng Zhou; Er-Hui Jiang; Xiao-Ping Zhao; Yong Song; Kai Song; Zhe Shao; Ke Liu; Zheng-Jun Shang
Journal:  Sci Rep       Date:  2017-01-23       Impact factor: 4.379

8.  The Stress-Inducible Peroxidase TSA2 Underlies a Conditionally Beneficial Chromosomal Duplication in Saccharomyces cerevisiae.

Authors:  Robert A Linder; John P Greco; Fabian Seidl; Takeshi Matsui; Ian M Ehrenreich
Journal:  G3 (Bethesda)       Date:  2017-09-07       Impact factor: 3.154

Review 9.  Cancer Cell Fusion: Mechanisms Slowly Unravel.

Authors:  Felicite K Noubissi; Brenda M Ogle
Journal:  Int J Mol Sci       Date:  2016-09-21       Impact factor: 5.923

10.  Hypoxia Enhances Fusion of Oral Squamous Carcinoma Cells and Epithelial Cells Partly via the Epithelial-Mesenchymal Transition of Epithelial Cells.

Authors:  Chun-Ming Huang; Ting-Lin Yan; Zhi Xu; Meng Wang; Xiao-Cheng Zhou; Er-Hui Jiang; Ke Liu; Zhe Shao; Zheng-Jun Shang
Journal:  Biomed Res Int       Date:  2018-02-08       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.